Referred to the House Committee on Ways and Means.
This bill (Diagnostic Accuracy in Sepsis Act of 2025) amends section 1886(p) of the Social Security Act to add blood culture contamination to the list of hospital-acquired conditions for the Medicare program. It specifies that, beginning with discharges in fiscal year 2026, blood culture contamination will be treated as a hospital-acquired condition.
Liberty/left emphasizes patient safety and quality improvement but wants accompanying funding and equity protections; conservatives emphasize regulatory burden and financial risk to hospitals.
Relative to its intended legislative type, this bill accomplishes a targeted substantive amendment to Medicare HAC law by adding blood culture contamination and demanding a 1% benchmark, but it leaves significant implementation specifics, definitions, timelines, and safeguards to administrative action.
This bill (Diagnostic Accuracy in Sepsis Act of 2025) amends section 1886(p) of the Social Security Act to add blood culture contamination to the list of hospital-acquired conditions for the Medicare program.
It specifies that, beginning with discharges in fiscal year 2026, blood culture contamination will be treated as a hospital-acquired condition.
The bill also directs the Secretary to create a measure for blood culture contamination and indicates that the contamination rate for hospitals should be established on the basis that it should not exceed 1 percent when determining whether a hospital is an applicable hospital under the cited subsection.
On content alone, this is a narrow, non-ideological Medicare technical change that could attract bipartisan interest from patient-safety advocates and quality-focused lawmakers; however, it alters provider payment incentives, lacks implementation detail or phase-in, and would likely draw opposition from provider groups and require CMS rulemaking. Those factors lower its standalone likelihood unless it is folded into a larger, negotiated health care or Medicare package.
Relative to its intended legislative type, this bill accomplishes a targeted substantive amendment to Medicare HAC law by adding blood culture contamination and demanding a 1% benchmark, but it leaves significant implementation specifics, definitions, timelines, and safeguards to administrative action.
Liberty/left emphasizes patient safety and quality improvement but wants accompanying funding and equity protections; conservatives emphasize regulatory burden and financial risk to hospitals.
These are examples from the analysis, not a ranked list of the most-affected groups.
Liberty/left emphasizes patient safety and quality improvement but wants accompanying funding and equity protections; conservatives emphasize regulatory burden and financial risk to hospitals.
A mainstream liberal would likely view this bill as a patient-safety–oriented measure that holds hospitals accountable for preventable laboratory errors that can harm diagnosis and treatment of sepsis.
They would see inclusion of blood culture contamination as a way to reduce misdiagnosis, unnecessary antibiotic use, and downstream morbidity.
At the same time, they would worry that treating contamination as a punishable metric without accompanying funding or support could disproportionately harm under-resourced and safety-net hospitals.
A pragmatic centrist would generally support a policy aimed at reducing preventable diagnostic errors and increasing measurement, while stressing the need for careful implementation.
They would want to see evidence that a 1% target is clinically and operationally feasible and would be cautious about unintended consequences from blunt payment incentives.
The centrist would favor a measured rollout, transparency in measurement methodology, and cost/benefit analysis before full enforcement.
A mainstream conservative would be skeptical of adding another federally defined hospital-acquired condition tied to Medicare program determinations, viewing it as increased federal regulation and potential financial penalty on hospitals.
They would share an interest in patient safety but worry that the bill imposes a one-size-fits-all 1% standard, expands federal oversight over clinical practice, and could harm hospitals financially—especially small, rural, or low-margin institutions.
They would prefer state-level flexibility, voluntary reporting or incentive-based approaches, and protections against unintended fiscal impacts.
Reached or meaningfully advanced
Reached or meaningfully advanced
Still ahead
Still ahead
Still ahead
On content alone, this is a narrow, non-ideological Medicare technical change that could attract bipartisan interest from patient-safety advocates and quality-focused lawmakers; however, it alters provider payment incentives, lacks implementation detail or phase-in, and would likely draw opposition from provider groups and require CMS rulemaking. Those factors lower its standalone likelihood unless it is folded into a larger, negotiated health care or Medicare package.
The bill has not accumulated any surfaced votes yet.
Liberty/left emphasizes patient safety and quality improvement but wants accompanying funding and equity protections; conservatives emphasi…
On content alone, this is a narrow, non-ideological Medicare technical change that could attract bipartisan interest from patient-safety ad…
Relative to its intended legislative type, this bill accomplishes a targeted substantive amendment to Medicare HAC law by adding blood culture contamination and demanding a 1% benchmark, but it leaves significant implem…
Go beyond the headline summary with full stakeholder mapping, legislative design analysis, passage barriers, and lens-by-lens tradeoff breakdowns.